NCT07504003 Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise
| NCT ID | NCT07504003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Endurance Exercise |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-08 |
| Primary Completion | 2028-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-04-08 with a primary completion date of 2028-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
During prolonged endurance exercise, certain physiological variables deteriorate depending on the duration of the exercise. Physiological resilience has therefore been defined as the ability to resist these changes and appears to be an important performance factor in endurance sports. For example, most studies in this field have investigated changes in cycling power output associated with the first ventilatory threshold (VT1), a marker of an individual's endurance capacity, after prolonged endurance exercise. To date, only two studies have examined the effects of training on resilience. The first compared the effectiveness of two training programs, one with low-intensity sessions and the other with high-intensity sessions, with no difference between the conditions. The second study showed that incorporating strength training into a running training program was more effective at improving resilience than running alone. However, the influence of training session duration on resilience remains unknown. Only one observational study has shown that in a group of runners of similar ability, those who were used to doing long sessions had better resilience than those who only did short sessions.
Eligibility Criteria
Inclusion Criteria: * Subjects who engage in rigorous cardiovascular activity (e.g., endurance sports, team sports, combat sports, etc.) for a maximum of two hours per week * Ability to understand, speak, read, and write French * Affiliated with or beneficiaries of a social security system * Having freely given their written consent after being informed of the purpose, procedure, and potential risks involved Exclusion Criteria: * Subjects with chronic joint conditions (e.g., recurrent sprains, patellar or ligament problems). * Subjects with one or more heart conditions, including ischemic, valvular, arrhythmic, hypertensive, congenital, or hypertrophic heart disease. * Participants under guardianship or conservatorship. * Subjects with chronic or central neurological conditions. * Subjects who report having taken products prohibited by the World Anti-Doping Agency. * Pregnant or breastfeeding women. * Subjects who are unable to understand the purpose and conditions of the study and unable to give their consent. * Persons deprived of their liberty by judicial or administrative decision, persons receiving psychiatric care under Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8, and persons admitted to a health or social care facility for purposes other than research.
Contact & Investigator
Léonard FEASSON, PHD
PRINCIPAL INVESTIGATOR
CHU de Saint-Etienne
Frequently Asked Questions
Who can join the NCT07504003 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Endurance Exercise. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07504003 currently recruiting?
Yes, NCT07504003 is actively recruiting participants. Contact the research team at leonard.feasson@chu-st-etienne.fr for enrollment information.
Where is the NCT07504003 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT07504003 clinical trial?
NCT07504003 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Léonard FEASSON, PHD at CHU de Saint-Etienne. The trial plans to enroll 40 participants.